Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKesson
Merck
Moodys
Harvard Business School

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Msd Merck Co Company Profile

See Plans and Pricing

« Back to Dashboard

Summary for Msd Merck Co
International Patents:142
US Patents:3
Tradenames:6
Ingredients:6
NDAs:7

Drugs and US Patents for Msd Merck Co

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Msd Merck Co ZOCOR simvastatin TABLET;ORAL 019766-004 Dec 23, 1991 AB RX Yes No   See Pricing   See Pricing
Msd Merck Co PIFELTRO doravirine TABLET;ORAL 210806-001 Aug 30, 2018 RX Yes Yes   See Pricing   See Pricing
Msd Merck Co ZOCOR simvastatin TABLET;ORAL 019766-005 Jul 10, 1998 AB RX Yes Yes   See Pricing   See Pricing
Msd Merck Co ZOCOR simvastatin TABLET;ORAL 019766-003 Dec 23, 1991 AB RX Yes No   See Pricing   See Pricing
Msd Merck Co SINGULAIR montelukast sodium TABLET, CHEWABLE;ORAL 020830-002 Mar 3, 2000 AB RX Yes No   See Pricing   See Pricing
Msd Merck Co SINGULAIR montelukast sodium TABLET;ORAL 020829-002 Feb 20, 1998 AB RX Yes Yes   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Msd Merck Co

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Msd Merck Co ZOCOR simvastatin TABLET;ORAL 019766-001 Dec 23, 1991 4,444,784*PED   See Pricing
Msd Merck Co ZOCOR simvastatin TABLET;ORAL 019766-005 Jul 10, 1998 4,444,784*PED   See Pricing
Msd Merck Co ZOCOR simvastatin TABLET;ORAL 019766-004 Dec 23, 1991 RE36481*PED   See Pricing
Msd Merck Co ZOCOR simvastatin TABLET;ORAL 019766-003 Dec 23, 1991 RE36520*PED   See Pricing
Msd Merck Co ZOCOR simvastatin TABLET;ORAL 019766-005 Jul 10, 1998 RE36520*PED   See Pricing
Msd Merck Co EMEND aprepitant FOR SUSPENSION;ORAL 207865-001 Dec 17, 2015 6,096,742   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for MSD MERCK CO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsule 40 mg, 80 mg and 125 mg ➤ Subscribe 2008-11-03
➤ Subscribe Injection 150 mg/vial ➤ Subscribe 2012-01-25
➤ Subscribe Tablets 10 mg ➤ Subscribe 2007-02-20
➤ Subscribe Injection 115 mg/vial ➤ Subscribe 2012-01-25
➤ Subscribe for Oral Suspension 125 mg/Kit ➤ Subscribe 2016-11-23
➤ Subscribe Chewable Tablets 4 mg and 5 mg ➤ Subscribe 2006-12-26

Supplementary Protection Certificates for Msd Merck Co Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2924034 CA 2019 00024 Denmark   See Pricing PRODUCT NAME: DORAVIRINE, LAMIVUDINE AND DISOPROXIL; REG. NO/DATE: EU/1/18/1333 20181126
0734381 PA2004002,C0734381 Lithuania   See Pricing PRODUCT NAME: 5-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUORMETIL)FENIL)ETOKSI)-3-(4-FLUORFENIL)-4-MORFOLINIL)METIL)-1,2-DIHIDRO-3H-1,2,4-TRIAZOL-3-ONAS (APREPITANTAS); REGISTRATION NO/DATE: EU/1/03/262/001, 2003 11 11, EU/1/03/262/002, 2003 11 11, EU/1/03/262/003, 2003 11 11, EU/1/03/262/004, 2003 11 11, EU/1/03/262/005, 2003 11 11, EU/1/03/262/006 20031111
0480717 98C0022 France   See Pricing PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
0734381 04C0010 France   See Pricing PRODUCT NAME: APREPITANT; REGISTRATION NO/DATE: EU/1/03/262/001 20031111
2552902 300980 Netherlands   See Pricing PRODUCT NAME: DORAVIRINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/18/1333/001-002 20181126
2552902 CA 2019 00025 Denmark   See Pricing PRODUCT NAME: DORAVIRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/18/1333 20181126
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Merck
McKesson
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.